Cargando…
Ranibizumab in patients with dense cataract and proliferative diabetic retinopathy with rubeosis
BACKGROUND: To evaluate the safety of ranibizumab as a surgical adjunct during cataract surgery in patients with proliferative diabetic retinopathy (PDR) with rubeosis, and to evaluate the efficacy and adverse effects of ranibizumab in treating PDR with rubeosis. MATERIALS AND METHODS: Three intravi...
Autores principales: | Tu, Yufei, Fay, Catherine, Guo, Suqin, Zarbin, Marco A., Marcus, Edward, Bhagat, Neelakshi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3574511/ https://www.ncbi.nlm.nih.gov/pubmed/23439790 http://dx.doi.org/10.4103/0974-620X.106099 |
Ejemplares similares
-
Gaining insight on mitigation of rubeosis iridis by UPARANT in a mouse model associated with proliferative retinopathy
por: Locri, Filippo, et al.
Publicado: (2020) -
Rubeosis iridis
por: Pagoulatos, Dionysios, et al.
Publicado: (2017) -
Ghost cell glaucoma after intravitreous injection of ranibizumab in proliferative diabetic retinopathy
por: Xu, Jun, et al.
Publicado: (2020) -
Pediatric open globe injury: A review of the literature
por: Li, Xintong, et al.
Publicado: (2015) -
Traumatic Macular Hole: Diagnosis, Natural History, and Management
por: Budoff, Greg, et al.
Publicado: (2019)